Head-to-head · WeighScore
AgelessRx vs LillyDirect Foundayo
By GLP-1 ScorecardUpdated
Score comparison
AgelessRx has the higher recorded score — 84.3/100 to 67.2/100.
AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Conventional and microdose GLP-1 programs with continuing care; branded prescriptions involve a separate pharmacy payment.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | AgelessRx | LillyDirect Foundayo |
|---|---|---|
| WeighScore | 84.3/100 | 67.2/100 |
| Grade | B | C |
| Site position | #17 | #185 |
| Semaglutide | Not verified (current medication-specific quote required) | Not disclosed |
| Tirzepatide | Microdose: $109 first month, then $318 every 2 months ($159/mo); full-dose quote required | Not disclosed |
| Coverage | Advertises US service; confirm treatment-specific state availability | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #17 · B
Strengths
- Conventional and lower-dose GLP-1 programs advertised
- Wegovy pens and oral-tablet consultations advertised
- Continuing messaging and check-ins advertised
What to consider
- Conventional medication-specific monthly quotes not verified
- Microdose introduction renews as a two-month charge
- Branded medication has a separate pharmacy bill
- Treatment-specific state eligibility and assigned dispenser need confirmation
Site position #185 · C
Strengths
- Manufacturer savings may be available to eligible patients; check the current terms and insurance requirements
- Direct from manufacturer — no compounding, no third-party reseller
- Daily oral tablet; the prescribing information permits taking it with or without food
- Available in all 50 states
What to consider
- Foundayo's placebo-controlled trial results do not establish a direct comparison with Wegovy or Zepbound
- Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
- $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
- Medication interactions and individual suitability need a prescriber's review
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.